Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
QNCX | Quince Therapeutics, Inc. | Chief Executive Officer, Director | Jan 3, 2022 | |||
LBPH | Longboard Pharmaceuticals, Inc. | Director | May 23, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|